Skip to content

SION SION Return on invested capital

Return on invested capital at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
26.8%+23.0pp
AbbVie logo
AbbVieABBV
17.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
-27.8%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-64.8%+100pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
17.5%+5.1pp

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

Based on trailing twelve months.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's return on invested capital?
SION (SION) reported return on invested capital of -38.8% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.